COL6A2 and CPXM1, both associated with extracellular matrix composition and remodeling, were found to increase susceptibility to osteoporosis [31], whereas SPARC exhibited a protective effect, consistent with its known roles in bone matrix mineralization and osteoblast function [32]. The gene discussed is CPXM1; the disease is osteoporosis.